Volume 58, Issue 5, Pages (November 2010)

Slides:

Advertisements

Similar presentations

Volume 60, Issue 4, Pages (October 2011)

Advertisements

Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular- cell neoplasia Paola Caria, Roberta Vanni Cancer Genetics and.

Volume 41, Issue 3, Pages (March 2002)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 1, Pages (July 2010)

Volume 63, Issue 2, Pages (February 2013)

Volume 70, Issue 1, Pages (July 2016)

Volume 56, Issue 5, Pages (November 2009)

2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections Rodolfo Montironi,

CD47 expression for in situ and invasive cutaneous epithelial lesions

Volume 52, Issue 1, Pages (July 2007)

Volume 57, Issue 3, Pages e22-e23 (March 2010)

Volume 61, Issue 5, Pages (May 2012)

Volume 52, Issue 3, Pages (September 2007)

Histologic Grading of Noninvasive Papillary Urothelial Neoplasms

Volume 53, Issue 5, Pages (May 2008)

Ziya Kirkali, Hein Van Poppel European Urology

Volume 73, Issue 5, Pages (May 2018)

Volume 64, Issue 3, Pages (September 2013)

Volume 52, Issue 3, Pages (September 2007)

Volume 58, Issue 1, Pages (July 2010)

Bladder Cancer: A Major Public Health Issue

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Handling and Pathology Reporting of Adrenal Gland Specimens

Volume 66, Issue 4, Pages (October 2014)

Volume 58, Issue 4, Pages (October 2010)

Volume 66, Issue 5, Pages (November 2014)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 50, Issue 4, Pages (October 2006)

On the Origin of Syn- and Metachronous Urothelial Carcinomas

Volume 54, Issue 6, Pages (December 2008)

Volume 70, Issue 1, Pages (July 2016)

Volume 56, Issue 2, Pages (August 2009)

Volume 60, Issue 5, Pages (November 2011)

Volume 61, Issue 3, Pages (March 2012)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Volume 56, Issue 6, Pages (December 2009)

Volume 50, Issue 3, Pages (September 2006)

Molecular Tumour Profiling for Detection of Biomarkers in Renal Cell Tumours Kerstin Junker, Jimsgene Sanjmyatav, Joerg Mueller, Thomas Steiner, Heiko.

Volume 59, Issue 3, Pages e7-e8 (March 2011)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 56, Issue 1, Pages (July 2009)

Volume 64, Issue 6, Pages (December 2013)

Volume 70, Issue 3, Pages e72-e74 (September 2016)

Volume 47, Issue 1, Pages (January 2005)

TERT Promoter Mutations Occur Frequently in Urothelial Papilloma and Papillary Urothelial Neoplasm of Low Malignant Potential Liang Cheng, Rodolfo Montironi,

Is Simple Enucleation a Minimal Partial Nephrectomy Responding to the EAU Guidelines’ Recommendations? Vincenzo Ficarra, Antonio Galfano, Stefano Cavalleri

Volume 62, Issue 3, Pages (September 2012)

Volume 50, Issue 5, Pages (November 2006)

Volume 55, Issue 6, Pages (June 2009)

2005 Update on Pathology of Prostate Biopsies with Cancer

Volume 66, Issue 6, Pages (December 2014)

ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung Anna Caliò, MD, Alessia Nottegar, MD, Eliana Gilioli, MD, Emilio Bria, MD, Sara.

Volume 63, Issue 2, Pages (February 2013)

Sergio Bracarda European Urology Supplements

Volume 52, Issue 3, Pages (September 2007)

European Urology is “Your” Journal

Volume 56, Issue 4, Pages (October 1999)

Volume 53, Issue 6, Pages (June 2008)

Volume 53, Issue 2, Pages (February 2008)

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Annika Berntsen, Poul F. Geertsen, Inge Marie Svane European Urology

Joaquim Bellmunt European Urology Supplements

Increased risk of solid renal tumors in lithium-treated patients

Jan Roigas European Urology Supplements

Pathology and Molecular Pathogenesis of Renal Cell Carcinoma

Volume 163, Issue 4, (November 2015)

Volume 51, Issue 5, Pages (May 2007)

2005 Update on Pathology of Prostate Biopsies with Cancer

H & E = hematoxylin and eosin.

Presentation transcript:

Volume 58, Issue 5, Pages 655-668 (November 2010) Prognostic and Therapeutic Impact of the Histopathologic Definition of Parenchymal Epithelial Renal Tumors Vincenzo Ficarra, Matteo Brunelli, Liang Cheng, Ziya Kirkali, Antonio Lopez-Beltran, Guido Martignoni, Rodolfo Montironi, Giacomo Novara, Hein Van Poppel European Urology Volume 58, Issue 5, Pages 655-668 (November 2010) DOI: 10.1016/j.eururo.2010.08.001 Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 1 Renal cell neoplasms (major histotypes): immunohistochemical and fluorescent in situ hybridization analysis. (A) Clear cell renal cell carcinoma (hematoxylin and eosin [H&E]); (B) immunoreactivity for CD10 and (C) loss of 3p (orange: CEP3; green: 3p); (D) papillary renal cell carcinoma (H&E); (E) immunoreactivity for CK7 and (F) gains of chromosomes 7 and 17 (orange CEP17; green CEP7); (G) chromophobe renal cell carcinoma (H&E), (H) immunoreactivity for parvalbumin and (I) loss of chromosome 6 (green: CEP 6); (J) renal oncocytoma (H&E), (K) immunoreactivity for S100A1, and (L) normal numerical complement of both chromosomes 2 and 6 (orange: CEP 2; green: CEP 6). European Urology 2010 58, 655-668DOI: (10.1016/j.eururo.2010.08.001) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 2 Recently described new entities: (A) clear cell papillary renal cell carcinoma; (B) renal cell carcinoma with prominent leiomyomatous proliferation; (C) tubulocystic renal cell carcinoma; (D) oncocytic papillary renal cell carcinoma. European Urology 2010 58, 655-668DOI: (10.1016/j.eururo.2010.08.001) Copyright © 2010 European Association of Urology Terms and Conditions